New all oral therapy for chronic hepatitis C virus (HCV)- A cost-benefit analysis
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.223
https://www.valueinhealthjournal.com/article/S1098-3015(14)00274-5/fulltext
Section Title :
Gastrointestinal Disorders
Section Order :
1260
First Page :
A37
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00274-5&doi=10.1016/j.jval.2014.03.223